Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

Offering cholesterol-reducing drugs earlier in life could cut even more heart attacks and strokes, new research suggests ...

Scientists are testing a new gene-editing treatment that could dramatically lower bad cholesterol and reduce the risk of ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

In a recent study, Verve's gene-editing therapy reduced cholesterol levels by 62% in patients receiving the highest dose.

Eli Lilly and Verve Therapeutics’ experimental gene-editing therapy VERVE-102 is showing promising results in lowering bad cholesterol with a single dose.

A phase 1 NEJM interim analysis found that a single infusion of the investigational base-editing therapy VERVE-102 produced ...

VERVE-102 is an investigational gene-editing therapy designed to permanently turn off the PCSK9 gene in the liver to reduce ...

Can an injection actually reduce cholesterol by 60 percent? Well, as per groundbreaking new gene therapy, it is believed that ...

High levels of LDL cholesterol increase the risk of plaque buildup in blood vessels, which can block blood flow to the heart.